Orbimed Advisors Llc Buys SPDR Biotech ETF, NeuroPace Inc, Janux Therapeutics Inc, Sells Haemonetics Corp, AbCellera Biologics Inc, Adverum Biotechnologies Inc

• New Purchases: XBI, NPCE, JANX, OMIC, SEM, TERN, DBTX, IKNA, GRPH, GHRS, GRAY, ACHL, VOR, NAUT, MAPS, AVTE, CVRX, CNVY, IPSC, CTMX, ALXO, GLUE, NRIX, ACRS, VERV, HSAQ, OGN, TALS, INZY, KZR, LBPH,
• Added Positions: DCPH, GH, IMGN, OSH, ANTM, VTGN, MRSN, MGTA, HUM, NVAX, ALXN, IMAB, MRTX, PCVX, SYBX, CRNX, HARP, OLMA, FLXN, JNCE, STRO, TRIL, KDNY, FLDM,
• Reduced Positions: ABCL, TBPH, PGNY, XENE, HZNP, NMTR, QURE, ARCT, VRTX, NTRA, SWTX, CRIS, SRPT, AMGN, NBIX, ASND, UNH, ABBV, NSTG, CRSP, BIIB, BNR, PPBT,
• Sold Out: HAE, ADVM, MOH, PAND, ALHC, TVTX, SSPK, OLK, LRMR, HCAT, NUVB, SGFY, FBRX, TCRR, NTLA, CMPS, INNV, SANA, SELB, ARYA,

For the details of ORBIMED ADVISORS LLC's stock buys and sells, go to https://www.gurufocus.com/guru/orbimed+advisors+llc/current-portfolio/portfolio

1. SpringWorks Therapeutics Inc (SWTX) - 6,044,266 shares, 5.17% of the total portfolio. Shares reduced by 2.3%
2. Bristol-Myers Squibb Company (BMY) - 4,515,400 shares, 3.13% of the total portfolio.
3. Edgewise Therapeutics Inc (EWTX) - 13,944,680 shares, 3.09% of the total portfolio.
4. Boston Scientific Corp (BSX) - 6,920,600 shares, 3.07% of the total portfolio.
5. Merck & Co Inc (MRK) - 3,732,400 shares, 3.02% of the total portfolio.

Orbimed Advisors Llc initiated holding in SPDR Biotech ETF. The purchase prices were between $122.48 and $139.69, with an estimated average price of $131.54. The stock is now traded at around $132.140000. The impact to a portfolio due to this purchase was 1.32%. The holding were 935,700 shares as of 2021-06-30.

Orbimed Advisors Llc initiated holding in NeuroPace Inc. The purchase prices were between $19.03 and $26.5, with an estimated average price of $23.2. The stock is now traded at around $21.620000. The impact to a portfolio due to this purchase was 0.99%. The holding were 4,012,281 shares as of 2021-06-30.

Orbimed Advisors Llc initiated holding in Janux Therapeutics Inc. The purchase prices were between $18.58 and $25.37, with an estimated average price of $22.27. The stock is now traded at around $32.425000. The impact to a portfolio due to this purchase was 0.9%. The holding were 3,466,386 shares as of 2021-06-30.

Orbimed Advisors Llc initiated holding in Singular Genomics Systems Inc. The purchase prices were between $23.16 and $31.17, with an estimated average price of $25.88. The stock is now traded at around $16.574200. The impact to a portfolio due to this purchase was 0.57%. The holding were 1,998,521 shares as of 2021-06-30.

Orbimed Advisors Llc initiated holding in Select Medical Holdings Corp. The purchase prices were between $34.1 and $43.08, with an estimated average price of $38.41. The stock is now traded at around $34.430000. The impact to a portfolio due to this purchase was 0.56%. The holding were 1,271,100 shares as of 2021-06-30.

Orbimed Advisors Llc initiated holding in Terns Pharmaceuticals Inc. The purchase prices were between $12.26 and $22, with an estimated average price of $17.16. The stock is now traded at around $12.290000. The impact to a portfolio due to this purchase was 0.48%. The holding were 3,791,204 shares as of 2021-06-30.

Orbimed Advisors Llc added to a holding in Deciphera Pharmaceuticals Inc by 138.78%. The purchase prices were between $32.73 and $47.95, with an estimated average price of $38.85. The stock is now traded at around $31.020000. The impact to a portfolio due to this purchase was 0.73%. The holding were 3,297,301 shares as of 2021-06-30.

Orbimed Advisors Llc added to a holding in Guardant Health Inc by 25.58%. The purchase prices were between $109.77 and $165.68, with an estimated average price of $134.96. The stock is now traded at around $124.920000. The impact to a portfolio due to this purchase was 0.32%. The holding were 1,227,400 shares as of 2021-06-30.

Orbimed Advisors Llc added to a holding in Immunogen Inc by 41.67%. The purchase prices were between $5.79 and $8.6, with an estimated average price of $7. The stock is now traded at around $6.005000. The impact to a portfolio due to this purchase was 0.26%. The holding were 12,936,622 shares as of 2021-06-30.

Orbimed Advisors Llc added to a holding in Oak Street Health Inc by 37.36%. The purchase prices were between $53.49 and $64.74, with an estimated average price of $59.39. The stock is now traded at around $46.290000. The impact to a portfolio due to this purchase was 0.22%. The holding were 1,328,300 shares as of 2021-06-30.

Orbimed Advisors Llc added to a holding in VistaGen Therapeutics Inc by 68.15%. The purchase prices were between $1.96 and $3.15, with an estimated average price of $2.46. The stock is now traded at around $2.990000. The impact to a portfolio due to this purchase was 0.19%. The holding were 14,467,872 shares as of 2021-06-30.

Orbimed Advisors Llc added to a holding in Mersana Therapeutics Inc by 47.97%. The purchase prices were between $13.28 and $18.07, with an estimated average price of $15.18. The stock is now traded at around $13.825000. The impact to a portfolio due to this purchase was 0.13%. The holding were 2,800,247 shares as of 2021-06-30.

Orbimed Advisors Llc sold out a holding in Haemonetics Corp. The sale prices were between $51.81 and $118.56, with an estimated average price of $71.78.

Orbimed Advisors Llc sold out a holding in Adverum Biotechnologies Inc. The sale prices were between $3.36 and $10.56, with an estimated average price of $5.5.

Orbimed Advisors Llc sold out a holding in Molina Healthcare Inc. The sale prices were between $230.67 and $268.74, with an estimated average price of $250.74.

Orbimed Advisors Llc sold out a holding in . The sale prices were between $60.05 and $60.05, with an estimated average price of $60.05.

Orbimed Advisors Llc sold out a holding in Alignment Healthcare Inc. The sale prices were between $20.57 and $27.27, with an estimated average price of $24.29.

Orbimed Advisors Llc sold out a holding in Silver Spike Acquisition Corp. The sale prices were between $13.98 and $20.21, with an estimated average price of $17.11.

Orbimed Advisors Llc reduced to a holding in AbCellera Biologics Inc by 24.12%. The sale prices were between $20.19 and $34.17, with an estimated average price of $27.71. The stock is now traded at around $17.070000. The impact to a portfolio due to this sale was -0.68%. Orbimed Advisors Llc still held 6,223,019 shares as of 2021-06-30.

Orbimed Advisors Llc reduced to a holding in Theravance Biopharma Inc by 26.61%. The sale prices were between $14.52 and $22.46, with an estimated average price of $18.8. The stock is now traded at around $8.330000. The impact to a portfolio due to this sale was -0.34%. Orbimed Advisors Llc still held 4,564,045 shares as of 2021-06-30.

Orbimed Advisors Llc reduced to a holding in Progyny Inc by 29.08%. The sale prices were between $44.51 and $64.95, with an estimated average price of $55.95. The stock is now traded at around $55.720000. The impact to a portfolio due to this sale was -0.25%. Orbimed Advisors Llc still held 1,365,445 shares as of 2021-06-30.

Orbimed Advisors Llc reduced to a holding in Xenon Pharmaceuticals Inc by 46.59%. The sale prices were between $16.81 and $20, with an estimated average price of $18.43. The stock is now traded at around $17.260000. The impact to a portfolio due to this sale was -0.21%. Orbimed Advisors Llc still held 1,334,217 shares as of 2021-06-30.

Orbimed Advisors Llc reduced to a holding in 9 Meters Biopharma Inc by 66.69%. The sale prices were between $1.04 and $1.5, with an estimated average price of $1.23. The stock is now traded at around $1.275000. The impact to a portfolio due to this sale was -0.2%. Orbimed Advisors Llc still held 8,565,974 shares as of 2021-06-30.